← Eichor
Study identifier: NCT06857851 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Optimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease

Condition: Parkinson's Disease  ·  Sponsor: VA Office of Research and Development

PhaseN/A
Planned participants80
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Inability to align and refocus the eyes on the objects at different depths, i.e., vergence impairment and strabismus, frequently affects the quality of life in patients with Parkinson's disease. The investigators study aims to understand the location-specific effects of subthalamic region deep brain stimulation on vergence and strabismus by integrating the patient-specific deep brain stimulation models and high-resolution eye-tracking measures. The knowledge gained will allow the investigators to find the most beneficial stimulation location and parameters for improving binocular coordination, strabismus, and vergence while preserving the ability to treat motor symptoms in Parkinson's disease.

This description comes directly from the study's public registry record.

Talk to the study team

Aasef G Shaikh, MD PhD  ·  (216) 791-3800  ·  Aasef.Shaikh@va.gov

Cheryl Dudek  ·  (216) 679-3800  ·  cheryl.dudek@va.gov

Always discuss trial participation with your own doctor first.

Locations (1)

Louis Stokes VA Medical Center, Cleveland, OHCleveland, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06857851